Viewing StudyNCT04088110



Ignite Creation Date: 2024-05-06 @ 1:40 PM
Last Modification Date: 2024-10-26 @ 1:18 PM
Study NCT ID: NCT04088110
Status: UNKNOWN
Last Update Posted: 2019-09-12
First Post: 2019-09-11

Brief Title: Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer
Sponsor: Fuzhou General Hospital
Organization: Fuzhou General Hospital

Conditions & Keywords Data

Conditions:
Name
Breast Cancer Female
HER2-positive Breast Cancer
Hormone Receptor Positive Malignant Neoplasm of Breast
Metastatic Breast Cancer
Breast Diseases
Hormone Receptor Positive Tumor
Keywords: